Product NDC: | 50111-456 |
Proprietary Name: | Oxybutynin Chloride |
Non Proprietary Name: | Oxybutynin Chloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Oxybutynin Chloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50111-456 |
Labeler Name: | Pliva Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071655 |
Marketing Category: | ANDA |
Start Marketing Date: | 19900930 |
Package NDC: | 50111-456-02 |
Package Description: | 500 TABLET in 1 BOTTLE (50111-456-02) |
NDC Code | 50111-456-02 |
Proprietary Name | Oxybutynin Chloride |
Package Description | 500 TABLET in 1 BOTTLE (50111-456-02) |
Product NDC | 50111-456 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Oxybutynin Chloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19900930 |
Marketing Category Name | ANDA |
Labeler Name | Pliva Inc. |
Substance Name | OXYBUTYNIN CHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |